Tesla plans to launch FSD in China in the first quarter of next year. Institutions say that the intelligent driving industry has reached a critical point.

On September 5, Tesla released its roadmap and expects to launch the Full Self-Driving (FSD) system in China and Europe in the first quarter of 2025, subject to regulatory approval. Ma Liang, from Anxin Securities, believes that recently multiple policies have been issued to support the development of smart driving. Combined with car companies actively promoting Urban NOA implementation, the turning point for the smart driving industry has arrived, and it is recommended to pay attention to relevant opportunities.

cls.cnSep 6 07:39

The State Tobacco Monopoly Administration has released new regulations on electronic cigarettes, and there is expected to be further improvement in market share for leading companies.

①The State Tobacco Monopoly Administration issued a notice on the amendment and issuance of the Regulations on the Management of Electronic Cigarette Trade. The notice mentions that the competent administrative department of the State Tobacco Monopoly Administration is to establish a national unified platform for the management of electronic cigarette trade. ②Lü Mingzhang of Caitong Securities pointed out that in the long run, non-compliant products will gradually be eliminated, and market share is expected to further concentrate, which is bullish for leading companies in production, brand and other aspects.

cls.cnSep 3 07:47

Hybio Pharmaceutical's H1 revenue continues to decline. Have active pharmaceutical ingredient orders become a "lifesaver"? | Interpretations

①In the first half of this year, hybio pharmaceutical's revenue decline trend has not stopped, and the net profit loss has narrowed to a certain extent; ②The formulation sector has been affected by block orders, with continuous revenue decline, and the active pharmaceutical ingredient sector has become the top revenue contributor; ③In the first half of this year, with efforts from multiple parties, hybio pharmaceutical has seen some relief in cash flow.

cls.cnAug 23 20:58

Hong Kong Digital Office sets up the Hong Kong "Cross-border Channel" self-service machine in Zhuhai, covering services such as talent immigration applications.

On August 23, the Hong Kong Digital Policy Office announced the establishment of a self-service machine for Hong Kong's "global top e-commerce" office in Zhuhai.

Zhitong FinanceAug 23 15:40

Suddenly surged by 110%! Monkeypox epidemic is spreading, and concept stocks are soaring across the board.

As a new round of monkeypox outbreaks catches market attention, pharmaceutical companies and related stocks involved in the production and development of monkeypox vaccines have seen a significant rise in their stock prices. The most ferocious performer is the monkeypox concept stock Geovax Labs in the US market, whose stock price surged by 110% last Friday; Emergent Biosolutions rose by over 24%.

券商中國Aug 19 07:56

Director of Shandong Jincheng Pharmaceutical Group investigated for suspected stock market manipulation. Q1 performance just turned around according to announcement.

On the evening of today, Shandong Jincheng Pharmaceutical Group announced that its actual controller and chairman, Zhao Yeqing, was under investigation for suspected illegal acts of market manipulation by the China Securities Regulatory Commission. Zhao Yeqing has been the chairman of Jincheng Pharmaceutical Group for 13 years. The last time he appeared in public was at the 3rd China Pharmaceutical and Chemical Conference two days ago. In Q1 of 2024, Jincheng Pharmaceutical Group has shown a good trend of reversing last year's poor performance.

cls.cnAug 16 22:45